GelStat (GelStat) Issuance of Stock : $0.00 Mil (TTM As of Dec. 2008)

View and export this data going back to 1996. Start your Free Trial

What is GelStat Issuance of Stock?

GelStat's Issuance of Stock for the three months ended in Dec. 2008 was $0.00 Mil.

GelStat's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2008 was $0.00 Mil.

GelStat Issuance of Stock Historical Data

The historical data trend for GelStat's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GelStat Issuance of Stock Chart

GelStat Annual Data

Trend

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Issuance of Stock

Get a 7-Day Free Trial

5.03

1.78

0.27

0.14

0.07

GelStat Quarterly Data
	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08
Issuance of Stock	Get a 7-Day Free Trial															-	-	-	-	-

GelStat Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

GelStat Issuance of Stock Related Terms

Thank you for viewing the detailed overview of GelStat's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

GelStat (GelStat) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GelStat Corp (OTCPK:GSAC) » Definitions » Issuance of Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 SE 2nd Avenue, Suite 2000, Miami, FL, USA, 33131

Website

https://www.gelstat.com

GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.

Executives

Adrian Graham Goldfarb	director	7660 CENTURION PARKWAY, SUITE 100, JACKSONVILLE FL 32256
Donald Miller	director, officer: Chief Financial Officer
Garry N Lowenthal	officer: Chief Financial Officer	2551 38TH AVENUE NE, STE 135, MINNEAPOLIS MN 55421

GelStat (GelStat) Headlines

No Headlines